Latest period
$11.91B
YoY change
-7.9%
5Y CAGR
-0.7%
Peak year (2021)
$15.23B
Latest annual
$12.85B
Free Cash Flow history chart for Bristol-Myers Squibb (BMY) from 1989 to 2025
Latest: $12.85B
Free Cash Flow growth chart for Bristol-Myers Squibb (BMY) from 1989 to 2025
Latest: -7.9%
Free Cash Flow history table for Bristol-Myers Squibb (BMY) from 1989 to 2025
| 2025 | $12.85B | -7.9% | −$1.10B | ||
| 2024 | $13.94B | +10.2% | +$1.29B | ||
| 2023 | $12.65B | +5.9% | +$703.00M | ||
| 2022 | $11.95B | -21.6% | −$3.29B | ||
| 2021 | $15.23B | +14.5% | +$1.94B | ||
| 2020 | $13.30B | +80.3% | +$5.92B | ||
| 2019 | $7.37B | +20.6% | +$1.26B | ||
| 2018 | $6.12B | +44.9% | +$1.90B | ||
| 2017 | $4.22B | +129.0% | +$2.38B | ||
| 2016 | $1.84B | +43.4% | +$558.00M | ||
| 2015 | $1.28B | -51.0% | −$1.34B | ||
| 2014 | $2.62B | -12.8% | −$386.00M | ||
| 2013 | $3.01B | -52.9% | −$3.38B | ||
| 2012 | $6.39B | +42.9% | +$1.92B | ||
| 2011 | $4.47B | +10.0% | +$406.00M | ||
| 2010 | $4.07B | +21.9% | +$732.00M | ||
| 2009 | $3.33B | +20.6% | +$569.00M | ||
| 2008 | $2.77B | +19.7% | +$456.00M | ||
| 2007 | $2.31B | +79.1% | +$1.02B | ||
| 2006 | $1.29B | +20.8% | +$222.00M | ||
| 2005 | $1.07B | -54.9% | −$1.30B | ||
| 2004 | $2.37B | -6.1% | −$155.00M | ||
| 2003 | $2.52B | -1164.1% | +$2.76B | ||
| 2002 | −$237.00M | -105.4% | −$4.62B | ||
| 2001 | $4.38B | +7.8% | +$316.00M | ||
| 2000 | $4.06B | +15.6% | +$548.00M | ||
| 1999 | $3.52B | +17.4% | +$521.00M | ||
| 1998 | $2.99B | +75.2% | +$1.28B | ||
| 1997 | $1.71B | -16.2% | −$331.00M | ||
| 1996 | $2.04B | +2.7% | +$54.00M | ||
| 1995 | $1.99B | +14.9% | +$258.00M | ||
| 1994 | $1.73B | -14.0% | −$282.00M | ||
| 1993 | $2.01B | +45.5% | +$629.00M | ||
| 1992 | $1.38B | +14.4% | +$174.00M | ||
| 1991 | $1.21B | -2.6% | −$32.00M | ||
| 1990 | $1.24B | +95.1% | +$604.00M | ||
| 1989 | $635.00M | — | — |
- 2025$12.85B-7.9%
- 2024$13.94B+10.2%
- 2023$12.65B+5.9%
- 2022$11.95B-21.6%
- 2021$15.23B+14.5%
- 2020$13.30B+80.3%
- 2019$7.37B+20.6%
- 2018$6.12B+44.9%
- 2017$4.22B+129.0%
- 2016$1.84B+43.4%
- 2015$1.28B-51.0%
- 2014$2.62B-12.8%
- 2013$3.01B-52.9%
- 2012$6.39B+42.9%
- 2011$4.47B+10.0%
- 2010$4.07B+21.9%
- 2009$3.33B+20.6%
- 2008$2.77B+19.7%
- 2007$2.31B+79.1%
- 2006$1.29B+20.8%
- 2005$1.07B-54.9%
- 2004$2.37B-6.1%
- 2003$2.52B-1164.1%
- 2002−$237.00M-105.4%
- 2001$4.38B+7.8%
- 2000$4.06B+15.6%
- 1999$3.52B+17.4%
- 1998$2.99B+75.2%
- 1997$1.71B-16.2%
- 1996$2.04B+2.7%
- 1995$1.99B+14.9%
- 1994$1.73B-14.0%
- 1993$2.01B+45.5%
- 1992$1.38B+14.4%
- 1991$1.21B-2.6%
- 1990$1.24B+95.1%
- 1989$635.00M—
Free Cash Flow values are taken from Bristol-Myers Squibb's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Bristol-Myers Squibb (BMY)
Free Cash Flow for Bristol-Myers Squibb (BMY): headline value $11.91B · YoY -7.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Bristol-Myers Squibb (BMY) free cash flow is $12.85B – declined 7.9% year-over-year.
Bristol-Myers Squibb free cash flow compound annual growth for the 2020–2025 (5 years) window is -0.7%, with a net decline across the window.
Bristol-Myers Squibb free cash flow peaked at $15.23B in 2021; the latest annual figure is $12.85B in 2025 (15.7% below peak).
2021 marks the peak free cash flow at $15.23B, with the historical low of −$237.00M recorded in 2002.
Bristol-Myers Squibb Free Cash Flow by Year
Bristol-Myers Squibb Free Cash Flow 2025: $12.85B
Bristol-Myers Squibb posted free cash flow of $12.85B in 2025, declined 7.9% below 2024.
Bristol-Myers Squibb Free Cash Flow 2024: $13.94B
In 2024, Bristol-Myers Squibb reported free cash flow of $13.94B, grew 10.2% from 2023.
Bristol-Myers Squibb Free Cash Flow 2023: $12.65B
Bristol-Myers Squibb free cash flow in 2023 was $12.65B, grew 5.9% from 2022.
Bristol-Myers Squibb Free Cash Flow 2022: $11.95B
2022's free cash flow for Bristol-Myers Squibb came in at $11.95B, declined 21.6% below 2021.
Bristol-Myers Squibb Free Cash Flow 2021: $15.23B
Bristol-Myers Squibb free cash flow in 2021 was $15.23B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by Free Cash Flow
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation